CVS: Value Hiding In Plain Sight

Summary

  • CVS is on track to achieve its debt reduction goals in the foreseeable future.
  • This will free up meaningful amounts of cash for shareholder returns.
  • Shares are very inexpensive, and could have significant upside potential. There are some risks to consider, however.
  • Looking for a helping hand in the market? Members of Cash Flow Kingdom get exclusive ideas and guidance to navigate any climate. Get started today ยป

Thesis

CVS Health (CVS) is a diversified healthcare company that has a strong track record and that should be able to capitalize on growing healthcare spending over the coming years as well. Right now shares are very inexpensive. As debt gets paid down over the coming years, while profits and cash flows continue to climb, a re-rating in CVS' valuation is not unlikely. A return to a higher (historically justified) valuation, and a resumption of dividend growth, could allow for meaningful returns over the coming years.

Buffett says to buy low, CVS HealthSource: imgflip.com

CVS Health Is An Underestimated Growth Company

According to some investors, CVS is not a growth company, is "dead money", etc. But the facts say that CVS is, quite contrary to public opinion, indeed a growth company:

ChartData by YCharts

Over the last 20 years, CVS Health has grown its revenues by 800%, its profits by 670%, and its cash flows by 1260%, all on a per-share basis. It should be noted that earnings per share, which have underperformed revenue per share, are artificially deflated by high non-cash amortization charges over the last couple of years. Adjusted for that, i.e. when we look at non-GAAP numbers, EPS growth would have been significantly higher. Even an EPS increase of 670% over 20 years is quite a feat, however, as this equates to an annual growth rate of 11%.

READ FULL ARTICLE HERE